ArticleCell death & disease2020

Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.

Jiajia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.